Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on LHC Group (LHCG) yesterday and set a price target of $125. The company’s shares closed yesterday at $110.25, close to its 52-week high of $116.74.
Wiederhorn wrote:
“LHCG reported Q1:19 adj. EPS of $0.98 (GAAP: $0.60), topping OPCO/Street consensus of $0.88/$0.89E. Adj. results exclude $0.17 of AFAM/acquisition costs, $0.07 related to closures, relocations, and consolidations and $0.14 for an impairment charge. The beat vs our model was largely driven by the tax rate. Admission trends softened up a little from their torrid pace in ’18, particularly in Medicare, but cost controls helped overcome the top-line pressure. Due to the tax-rate adjustment and cost controls, the company raised FY2019 EPS guidance to $4.25-$4.35 vs $4.15- $4.25.”
According to TipRanks.com, Wiederhorn is a 5-star analyst with an average return of 13.2% and a 62.5% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Addus Homecare Corp, and Community Health.
LHC Group has an analyst consensus of Moderate Buy, with a price target consensus of $122.
See today’s analyst top recommended stocks >>
Based on LHC Group’s latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of $20.55 million. In comparison, last year the company had a net profit of $5 million.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
